Anders Ullén

4.3k citations
100 papers · 3.1k · 3 hit papers · h-index 21

Impact in

  • Surgery top 2%
    • Bladder and Urothelial Cancer Treatments
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Bone health and treatments

Papers in

    • Bladder and Urothelial Cancer Treatments 47
    • Prostate Cancer Treatment and Research 18
    • Prostate Cancer Diagnosis and Treatment 7
    • Renal cell carcinoma treatment 2

Anders Ullén

93 papers receiving 3k citations

Anders Ullén's Hit Papers

Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up 2023 · 153 citations
1530+2+4Years since publication2505007501k

Peers

Anders Ullén
Comparison fields: 5 of 89
  • Surgery 1.4k
  • Oncology 615
  • Pulmonary and Respiratory Medicine 568
  • Cancer Research 172
  • Radiology, Nuclear Medicine and Imaging 172
Replace Daniel A. Vaena with:
Daniel A. Vaena United States
Rafael Morales‐Barrera Spain
Tanja Trarbach Germany
Francesco Leone Italy
Stacey Stein United States
Ying‐Chun Shen Taiwan
Daniele Raggi Italy
Patrizia Giannatempo Italy
Oyewale O. Abidoye United States
Saeed Sadeghi United States
Anders Ullén relative to Daniel A. Vaena United States Daniel A. Vaena's profile →
Citations per field
00.5×1.5×2×2.3×
Daniel A. Vaena · 1×
Citations per year

Countries citing papers authored by Anders Ullén

Since Specialization
Citations

This map shows the geographic impact of Anders Ullén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Ullén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Ullén more than expected).

Fields of papers citing papers by Anders Ullén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Ullén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Ullén. The network helps show where Anders Ullén may publish in the future.

Co-authors

The 25 scholars most cited alongside Anders Ullén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anders Ullén Line = papers co-authored together Anders Ullén links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
Hit paper breakdown →
20201096
2 2011227
3
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up
Hit paper breakdown →
2023153
4 2018151
5 2013144
6 2015133
7 2018117
8
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
Hit paper breakdown →
2021117
9 200560
10 201656
11 201248
12 202344
13 201138
14 201633
15 201529
16 201428
17 202024
18 201723
19 200822
20
Use of anticytokeratin monoclonal anti-idiotypic antibodies to improve tumor:nontumor ratio in experimental radioimmunolocalization.
199521

About Anders Ullén

Anders Ullén is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology, having authored 100 papers that have together received 3.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (47 papers), Prostate Cancer Treatment and Research (18 papers), Radiopharmaceutical Chemistry and Applications (12 papers), Prostate Cancer Diagnosis and Treatment (7 papers), Bone health and treatments (6 papers), Extracellular vesicles in disease (5 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Surgery (1.4k citations), Oncology (615 citations), Pulmonary and Respiratory Medicine (568 citations), Cancer Research (172 citations) and Radiology, Nuclear Medicine and Imaging (172 citations). Anders Ullén has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Sten F. Nilsson, Amir M. Sherif, Per‐Uno Malmström, Robert Rosenblatt, Rolf Wahlqvist, Erkki Rintala, Theocharis Panaretakis, Jeffrey Yachnin, Lena Lennartsson and Pedro Fonseca. Their work appears in journals such as Acta Oncologica, European Urology, Cancer, European Journal of Cancer and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact